₩38,400.00 ($28.59)

-1250.00 (-3.15%)

Weekly Expected Move ±3.4%

₩35808 ₩37104 ₩38400 ₩39696 ₩40992

KOE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · ₩1.70T mcap · 20M float · 0.477% daily turnover

Operating Cash Flow

$82.8B +46.3% ▲

5Y CAGR: +18.0%

Capital Expenditures

$16.2B -170.2% ▼

5Y CAGR: -18.2%

Free Cash Flow

$66.6B +31.6% ▲

Dividends Paid

$0 +0.0% ▲

Buybacks

$2.4B +50.4% ▲

Net Change in Cash

$4.4B -83.0% ▼

View Full Cash Flow Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
— Operating Activities —
Net Income	$34.6B	$26.0B	$21.3B	$22.0B	$38.8B
Depreciation & Amort.	$16.4B	$17.4B	$19.7B	$20.1B	$22.3B
Stock-Based Comp.	$1.5B	$1.7B	$2.7B	$2.8B	$0
Change in Working Capital	$25.9B	-$70.5B	-$41.0B	-$9.5B	$14.4B
Other Non-Cash Items	$9.5B	$16.2B	-$898M	$21.2B	$7.4B
Operating Cash Flow	$87.8B	-$9.2B	$1.8B	$56.6B	$82.8B
— Investing Activities —
Capital Expenditures	-$12.5B	-$6.3B	-$6.9B	-$4.9B	-$17.9B
Acquisitions (Net)	$0	$1M	$0	$0	$28M
Investment Purchases	-$21.0B	-$39.0B	-$54.5B	-$59.1B	-$234.1B
Investment Sales	$17.0B	$30.0B	$54.7B	$52.4B	$191.5B
Other Investing	-$51M	-$126M	$1.1B	-$477M	$686M
Investing Cash Flow	-$16.5B	-$15.4B	-$5.5B	-$12.1B	-$59.8B
— Financing Activities —
Net Debt Issuance	-$11.9B	-$19.8B	-$2.1B	-$3.3B	-$12.9B
Stock Repurchased	-$5.2B	-$4.6B	-$4.3B	-$4.9B	-$2.4B
Dividends Paid	$0	$0	$0	$0	$0
Other Financing	-$598M	-$605M	-$2.2B	-$11.4B	-$3.5B
Financing Cash Flow	-$16.8B	-$24.2B	-$8.0B	-$18.7B	-$18.6B

Net Change in Cash	$54.4B	-$48.8B	-$11.7B	$25.8B	$4.4B
Cash End of Period	$80.2B	$31.4B	$19.7B	$45.5B	$49.9B
Free Cash Flow	$75.3B	-$15.5B	-$5.1B	$50.6B	$66.6B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
— Operating Activities —
Net Income	$8.3B	$6.2B	$7.3B	$11.1B	$11.5B	$8.9B	$8.8B	$13.7B
Depreciation & Amort.	$5.1B	$4.8B	$5.3B	$5.5B	$5.7B	$5.7B	$6.2B	$5.6B
Stock-Based Comp.	$885M	$638M	$0	$891M	$594M	$560M	$829M	$0
Change in Working Capital	-$2.4B	$9.9B	$29.5B	-$5.8B	$3.5B	-$12.8B	$17.4B	-$24.7B
Other Non-Cash Items	$8.2B	$8.2B	$315M	$1.6B	$2.2B	$4.9B	$564M	$2.1B
Operating Cash Flow	$20.1B	$29.8B	$42.4B	$13.4B	$23.4B	$7.2B	$33.8B	-$3.1B
— Investing Activities —
Capital Expenditures	-$1.1B	-$1.9B	-$7.9B	-$4.4B	-$2.1B	-$3.2B	-$3.1B	$4.7B
Acquisitions (Net)	$0	$0	$0	$0	$0	$0	$0	$592K
Investment Purchases	-$16.1B	-$15.0B	-$31.0B	-$38.0B	-$105.1B	-$59.9B	-$46.0B	-$42.0B
Investment Sales	$18.9B	$12.0B	$6.0B	$14.0B	$85.2B	$86.3B	$36.0B	$47.0B
Other Investing	$307M	-$931M	$308M	$889M	$529M	$768M	-$11.7B	$35M
Investing Cash Flow	$2.1B	-$5.8B	-$32.6B	-$27.6B	-$21.4B	$24.0B	-$24.8B	$9.8B
— Financing Activities —
Net Debt Issuance	-$3.8B	-$4.3B	-$4.9B	$514M	$262M	-$8.8B	$0	$0
Stock Repurchased	$0	$0	$0	-$2.4B	$0	$0	$0	-$2.2B
Dividends Paid	$0	$0	$0	$0	$0	$0	$0	-$8.7B
Other Financing	-$2.7B	-$2.4B	-$2.3B	-$2.4B	-$2.4B	-$2.3B	-$2.3B	-$897M
Financing Cash Flow	-$6.3B	-$6.6B	-$7.2B	-$4.2B	-$2.1B	-$10.9B	-$2.2B	-$11.8B

Net Change in Cash	$15.9B	$17.4B	$2.6B	-$18.4B	-$59M	$20.3B	$6.9B	-$5.1B
Cash End of Period	$28.1B	$45.5B	$48.1B	$29.7B	$29.6B	$49.9B	$56.8B	$51.7B
Free Cash Flow	$18.9B	$27.6B	$34.9B	$8.5B	$21.2B	$4.4B	$18.4B	-$7.0B

068760.KQ KOE